BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21631573)

  • 1. Ecstasy use and suicidal behavior among adolescents: findings from a national survey.
    Kim J; Fan B; Liu X; Kerner N; Wu P
    Suicide Life Threat Behav; 2011 Aug; 41(4):435-44. PubMed ID: 21631573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Past 12-month and lifetime comorbidity and poly-drug use of ecstasy users among young adults in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Keyes KM; Martins SS; Hasin DS
    Drug Alcohol Depend; 2008 Sep; 97(1-2):139-49. PubMed ID: 18524499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of adolescent suicide across patterns of drug use: a nationally representative study of high school students in the United States from 1999 to 2009.
    Wong SS; Zhou B; Goebert D; Hishinuma ES
    Soc Psychiatry Psychiatr Epidemiol; 2013 Oct; 48(10):1611-20. PubMed ID: 23744443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults.
    Jones GM; Nock MK
    J Psychopharmacol; 2022 Jan; 36(1):46-56. PubMed ID: 34983249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An examination of sociodemographic correlates of ecstasy use among high school seniors in the United States.
    Palamar JJ; Kamboukos D
    Subst Use Misuse; 2014 Nov; 49(13):1774-83. PubMed ID: 24955818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do adolescent ecstasy users have different attitudes towards drugs when compared to marijuana users?
    Martins SS; Storr CL; Alexandre PK; Chilcoat HD
    Drug Alcohol Depend; 2008 Apr; 94(1-3):63-72. PubMed ID: 18068314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contextualising psychological distress among regular ecstasy users: the importance of sociodemographic factors and patterns of drug use.
    George J; Kinner SA; Bruno R; Degenhardt L; Dunn M
    Drug Alcohol Rev; 2010 May; 29(3):243-9. PubMed ID: 20565515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlates of Ecstasy use among tenth graders surveyed through monitoring the future.
    Yacoubian GS
    J Psychoactive Drugs; 2002; 34(2):225-30. PubMed ID: 12691213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twelve-month suicidal symptoms and use of services among adolescents: results from the National Comorbidity Survey.
    Husky MM; Olfson M; He JP; Nock MK; Swanson SA; Merikangas KR
    Psychiatr Serv; 2012 Oct; 63(10):989-96. PubMed ID: 22910768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proximally-occurring life events and the first transition from suicidal ideation to suicide attempt in adolescents.
    Paul E
    J Affect Disord; 2018 Dec; 241():499-504. PubMed ID: 30149338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ecstasy use and associated risk factors among Asian-American youth: findings from a national survey.
    Wu P; Liu X; Kim J; Fan B
    J Ethn Subst Abuse; 2011; 10(2):112-25. PubMed ID: 21678145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of ecstasy and other psychoactive substances among school-attending adolescents in Taiwan: national surveys 2004-2006.
    Chen WJ; Fu TC; Ting TT; Huang WL; Tang GM; Hsiao CK; Chen CY
    BMC Public Health; 2009 Jan; 9():27. PubMed ID: 19159468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of Suicidal Behaviors in Canadian Adolescents with No Recent History of Depression.
    Weeks M; Colman I
    Arch Suicide Res; 2017; 21(2):354-364. PubMed ID: 27587262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The variety of ecstasy/MDMA users: results from the National Epidemiologic Survey on alcohol and related conditions.
    Wu LT; Parrott AC; Ringwalt CL; Yang C; Blazer DG
    Am J Addict; 2009; 18(6):452-61. PubMed ID: 19874166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs.
    Halpern JH; Sherwood AR; Hudson JI; Gruber S; Kozin D; Pope HG
    Addiction; 2011 Apr; 106(4):777-86. PubMed ID: 21205042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences between Ecstasy-using and nonusing methamphetamine users.
    Brecht ML; von Mayrhauser C
    J Psychoactive Drugs; 2002; 34(2):215-23. PubMed ID: 12691212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depressed mood, suicidal behaviors, and health risk behaviors among youths in the Commonwealth of the Northern Mariana Islands: the 2017 CNMI Youth Risk Behavior Survey.
    Sakamoto JL; Shibanuma A; Jimba M
    BMC Public Health; 2020 Apr; 20(1):489. PubMed ID: 32293384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Injection drug use is associated with suicide attempts but not ideation or plans in a sample of adolescents with depressive symptoms.
    Liu RT; Case BG; Spirito A
    J Psychiatr Res; 2014 Sep; 56():65-71. PubMed ID: 24853457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shifting characteristics of ecstasy users ages 12-34 in the United States, 2007-2014.
    Palamar JJ; Mauro PM; Han BH; Martins SS
    Drug Alcohol Depend; 2017 Dec; 181():20-24. PubMed ID: 29028555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polysubstance use and its correlates in adolescent ecstasy users in Taiwan.
    Yen CF; Hsu SY; Cheng CP
    Addict Behav; 2007 Oct; 32(10):2286-91. PubMed ID: 17314013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.